Dr. Benjamin Solomon, lead investigator and medical oncologist at Peter MacCallum Cancer Centre, Melbourne, Australia joined Dr. Jack West at the IASLC World Conference on Lung Cancer in Barcelona, Spain to discuss his journey to thoracic oncology, why he chose to focus on Alk+ Non- Small Cell Cancer and lung cancer trends Australia.

Dr. Ramon Rami Porta, Clinical Chief of the Department of Thoracic Surgery at Hospital Universitari Mútua Terrassa, in Terrassa (Barcelona), Spain, joins Dr. Jack West for a discussion on the importance of lung cancer tumor staging, the status of CT Screening for lung cancer prevention in Europe and a preview of the IASLC World Conference on Lung Cancer in Barcelona. Listen to the end to get some tips on Barcelona culture, food and a great tip for waking up in the morning after a late dinner!

Dr. Jack West is joined by Dr. Christine Lovly to discuss highlights from the 2019 ASCO Annual Meeting. Dr. Lovly is associate professor of medicine at Vanderbilt University Medical Center in Nashville, Tennessee.

Dr. Jack west is joined by Dr. Alex Adjei, Professor of Medicine, Professor of Medical Oncology and Editor-in-Chief at the Journal of Thoracic Oncology. Dr. West and Dr. Adjei discuss the evolution of the Journal of Thoracic Oncology and the impact it has on lung cancer awareness for professionals.

Dr. Jack West is joined by Dr. Alexander Drilon to discuss the challenge of NGS testing and increased participation and funding in lung cancer clinical trials. Dr. Drilon is Associate Attending Physician and Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center in New York. Dr. Drilon has been at the forefront of development of many novel targeted therapies for some of the newest biomarker-driven therapies for advanced non-small cell.

Dr. Jack West is joined by Dr. Anne Tsao for a conversation on the state of treatment of mesothelioma in anticipation of the first IASLC 2019 Mesothelioma Meeting July 10-12, 2019 in New York, NY. Dr. Tsao is Professor in the Department of Thoracic Head and Neck Medical Oncology in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston. She is also Director of the Mesothelioma Program and Director of the Thoracic Chemo Radiation program.

Dr. Jack West is joined by Dr. Corey Langer to discuss lung cancer management, niche patients including PS2 and elderly patients, the evolution of small cell lung cancer treatment and care, and chemo immunotherapy. Dr. Langer is Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania in Philadelphia.

Dr. Jack West is joined by Dr. Walter J. Curran for discussions on radiation oncology, immunotherapy and the interaction with radiation, and the evolution of proton therapy including growth of the field and access to treatment. Dr. Curran is Executive director of the Winship Cancer Institute of Emory University and current chair of the NRG Oncology Group.

Dr. Jack West is joined by Dr. David Spigel to discuss medication for lung cancer treatment, checkpoint inhibitor therapy and the future of duration of treatment for lung cancer patients. Dr. Spigel is Chief Scientific Officer at Sarah Cannon Research Institute in Nashville, Tennessee. Dr. Spigel is a medical oncologist with a particular focus on thoracic oncology.

IASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. William Travis, Attending Thoracic Pathologist at Memorial Sloan Kettering Cancer Center in New York. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.